News and perspectives from corporations working to directly impact the COVID-19 public health crisis. Content from this collection may include updates from medical supply or pharmaceutical companies, businesses that have pivoted their production to support the medical response to COVID-19 or hospitals that are navigating many secondary impacts of the pandemic (both economic and human).
FDA Commissioner Stephen Hahn tweeted Friday that the agency “is finalizing the necessary documents to ensure that patients and providers have the information that they need to make informed decisions.”
The Food and Drug Administration said the first Covid-19 vaccine being considered for U.S. distribution “met the prescribed success criteria” in a clinical study, paving the way for the agency to green-light distribution as early as this weekend.
The federal government plans to send 6.4 million doses of pharmaceutical giant Pfizer’s coronavirus vaccine to communities across the United States within 24 hours of regulatory clearance, with the expectation that shots will be administered quickly to front-line health-care workers, the top priority group, officials said Tuesday.
In April, less than a month after Covid-19 was officially declared a pandemic, Dolly Parton donated $1 million to coronavirus research at Vanderbilt University.
More than seven months later, it's been revealed that the legendary performer's donation helped fund Moderna's Covid-19 vaccine, which this week became the second coronavirus vaccine with a stunningly high success rate.
This time last year — as China's perishing winter descended across most of the country — rumours about a strange new flu were beginning to circulate in Wuhan. On China's social media platform WeChat, users had been discussing their coughs and colds for weeks with words like "SARS" and "shortness of breath" spiking from mid-November.
McDonald's Corp MCD.N will inspect all its U.S. restaurants to ensure compliance with safety standards as coronavirus cases surge again and "COVID fatigue" sets in, according to an internal note seen by Reuters on Friday.
By: Richa Naidu, Victoria Waldersee, Siddharth Cavale
Source: Reuters
Date of Publication: November 13th, 2020
When rumors first began to circulate that the UK would go back into lockdown, Leanne Barnes despaired as bread and toilet roll flew off the shelves again at her local supermarket. But to her surprise, shelves were back to being fully stocked within a few days.
Moderna Inc's MRNA.O experimental vaccine is 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report results that far exceed expectations.
Uncertainty can be disorienting and disruptive. Learn from business leaders about what it’s like to navigate their organizations and people through a global pandemic.